Personal information

No personal information available

Activities

Collapse all

Works (49)

Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer

Molecular Cancer Therapeutics
2024-04-02 | Journal article
DOI: 10.1158/1535-7163.MCT-23-0371
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Data from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.c.7160210
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Data from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.c.7160210.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Data S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523285
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Data S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523285.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523282.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523282
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523279.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523279
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S11 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523276
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S11 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523276.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523273
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523273.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523270
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523270.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523267
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523267.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523264
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523264.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523261
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523261.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523258
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523258.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523255.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523255
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523252
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523252.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523249
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523249.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S2 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523246
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S2 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523246.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S3 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523243
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S3 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523243.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S4 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523240
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S4 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523240.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S5 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523237
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S5 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523237.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S6 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523234.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S6 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523234
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S7 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523231
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

Supplementary Table S7 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in <i>EGFR</i> Mutation–positive Lung Cancer

2024-04-02 | Preprint
DOI: 10.1158/1535-7163.25523231.v1
Contributors: Tatsuya Ogimoto; Hiroaki Ozasa; Takahiro Tsuji; Tomoko Funazo; Masatoshi Yamazoe; Kentaro Hashimoto; Hiroshi Yoshida; Kazutaka Hosoya; Hitomi Ajimizu; Takashi Nomizo et al.
Source: check_circle
Crossref

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Nature Communications
2020-01-03 | Journal article
DOI: 10.1038/s41467-019-13771-5
Contributors: Takahiro Tsuji; Hiroaki Ozasa; Wataru Aoki; Shunsuke Aburaya; Tomoko Yamamoto Funazo; Koh Furugaki; Yasushi Yoshimura; Masatoshi Yamazoe; Hitomi Ajimizu; Yuto Yasuda et al.
Source: check_circle
Crossref

Impact of urinary tract infection on nursing and healthcare-associated pneumonia

Journal of Infection and Chemotherapy
2019-12 | Journal article
DOI: 10.1016/j.jiac.2019.05.016
Contributors: Masatoshi Yamazoe; Hiromi Tomioka; Takamasa Wada
Source: check_circle
Crossref

Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion

Journal of Thoracic Oncology
2019-11 | Journal article
DOI: 10.1016/j.jtho.2019.06.007
Contributors: Masatoshi Yamazoe; Hiroaki Ozasa; Young Hak Kim
Source: check_circle
Crossref

Ten-year experience of smoking cessation in a single center in Japan.

Respiratory investigation
2019-02-19 | Journal article
DOI: 10.1016/j.resinv.2019.01.007
PMID: 30795920
Source: Self-asserted source
masatoshi yamazoe

Mycoplasma hominis empyema following caesarean section

Respirology Case Reports
2018-11 | Journal article
DOI: 10.1002/rcr2.367
Contributors: Masatoshi Yamazoe; Hiromi Tomioka; Shuji Yamashita; Kazusa Egami; Kouji Oh
Source: check_circle
Crossref

Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report.

Respiratory medicine case reports
2018-11-19 | Journal article
DOI: 10.1016/j.rmcr.2018.11.011
PMID: 30533375
PMC: PMC6260452
Source: Self-asserted source
masatoshi yamazoe

Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.

BMJ open respiratory research
2018-10-09 | Journal article
DOI: 10.1136/bmjresp-2018-000342
PMID: 30397488
PMC: PMC6203000
Source: Self-asserted source
masatoshi yamazoe

Significance of blood cultures in nursing home-acquired pneumonia.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2017-12-29 | Journal article
DOI: 10.1016/j.jiac.2017.11.012
PMID: 29292179
Source: Self-asserted source
masatoshi yamazoe
How many people are using ORCID?